Optimi Health(OPTH)
$2.40+0.15 (+6.43%)
OPTH
Optimi Health financials statements
$2.40
At close:+0.15 (+6.43%)
Optimi Health (OPTH) Ratios
27 Followers
Optimi Health Ratios
OPTH's free cash flow for Q3 2026 was C$-2.87M. For the 2026 fiscal year, OPTH's free cash flow was decreased by C$-22.10K and operating cash flow was C$-2.85M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.22 | 0.38 | 1.51 | 3.33 | 6.39 |
| Quick Ratio | 0.18 | 0.11 | 1.02 | 2.97 | 6.33 |
| Cash Ratio | 0.13 | 0.03 | 0.84 | 2.59 | 3.76 |
| Solvency Ratio | -0.32 | -1.04 | -1.36 | -8.88 | -2.50 |
| Operating Cash Flow Ratio | -0.31 | -1.33 | -2.24 | -6.29 | -2.69 |
| Short-Term Operating Cash Flow Coverage | -0.41 | -4.46 | -98.12 | -51.99 | -63.16 |
| Net Current Asset Value | C$ -6.82M | C$ -3.74M | C$ -852.38K | C$ 1.63M | C$ 11.91M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.44 | 0.19 | 0.10 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 1.02 | 0.29 | 0.13 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.50 | 0.22 | 0.11 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.16 | 0.11 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.32 | 1.52 | 1.25 | 1.05 | 1.11 |
| Debt Service Coverage Ratio | -0.32 | -3.41 | -54.98 | -60.79 | -51.97 |
| Interest Coverage Ratio | -8.52 | -13.06 | -100.23 | -263.99 | -315.65 |
| Debt to Market Cap | 0.17 | 0.13 | 0.10 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.25 | 0.04 | 0.02 | 0.00 | 0.00 |
| Net Debt to EBITDA | -2.48 | -0.56 | -0.08 | 0.25 | 1.37 |
| Profitability Margins | |||||
| Gross Profit Margin | -486.44% | 69.49% | -86.72% | 66.80% | 0.00% |
| EBIT Margin | -746.03% | -1438.12% | -2844.40% | -9072.23% | 0.00% |
| EBITDA Margin | -523.11% | -1215.49% | -2441.53% | -8708.50% | 0.00% |
| Operating Profit Margin | -1062.29% | -1438.81% | -2419.07% | -9155.17% | 0.00% |
| Pretax Profit Margin | -870.75% | -1548.25% | -2868.54% | -9106.91% | 0.00% |
| Net Profit Margin | -870.75% | -1548.25% | -2868.54% | -9141.59% | 0.00% |
| Continuous Operations Profit Margin | -870.75% | -1548.25% | -2868.54% | -9106.91% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.38% | 100.32% |
| EBT Per EBIT | 81.97% | 107.61% | 118.58% | 99.47% | 99.41% |
| Return on Assets (ROA) | -24.40% | -41.48% | -31.50% | -43.88% | -25.74% |
| Return on Equity (ROE) | -56.49% | -63.03% | -39.32% | -46.06% | -28.66% |
| Return on Capital Employed (ROCE) | -67.30% | -49.49% | -29.44% | -45.93% | -28.53% |
| Return on Invested Capital (ROIC) | -34.53% | -45.50% | -29.29% | -45.41% | -28.28% |
| Return on Tangible Assets | -24.40% | -41.48% | -31.50% | -43.88% | -25.74% |
| Earnings Yield | -9.92% | -28.09% | -32.28% | -30.54% | -13.50% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.48 | 3.14 | 1.09 | 0.82 | 0.00 |
| Payables Turnover | 2.11 | 0.16 | 0.32 | 0.05 | 0.02 |
| Inventory Turnover | 8.05 | 0.13 | 0.43 | 0.10 | 0.38 |
| Fixed Asset Turnover | 0.03 | 0.03 | 0.01 | 0.01 | 0.00 |
| Asset Turnover | 0.03 | 0.03 | 0.01 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | -0.10 | -0.67 | 0.14 | 0.01 | 0.00 |
| Cash Conversion Cycle | -46.41 | 562.57 | 28.64 | -3521.33 | -15380.03 |
| Days of Sales Outstanding | 81.39 | 116.23 | 334.06 | 446.33 | 0.00 |
| Days of Inventory Outstanding | 45.32 | 2746.00 | 841.22 | 3605.52 | 954.69 |
| Days of Payables Outstanding | 173.11 | 2299.67 | 1146.64 | 7573.17 | 16334.73 |
| Operating Cycle | 126.70 | 2862.23 | 1175.28 | 4051.85 | 954.69 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.82 | -0.05 | -0.04 | -0.06 | -0.09 |
| Free Cash Flow Per Share | -0.85 | -0.05 | -0.05 | -0.15 | -0.16 |
| Dividend Paid and CapEx Coverage Ratio | -29.73 | -28.10 | -4.48 | -0.64 | -1.22 |
| Capital Expenditure Coverage Ratio | -29.73 | -28.10 | -4.48 | -0.64 | -1.22 |
| Operating Cash Flow Coverage Ratio | -0.39 | -1.56 | -2.11 | -29.06 | -24.01 |
| Operating Cash Flow to Sales Ratio | -6.16 | -10.98 | -19.89 | -56.74 | 0.00 |
| Free Cash Flow Yield | -7.26% | -20.63% | -27.38% | -48.55% | -24.51% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.08 | -3.56 | -3.10 | -3.27 | -7.41 |
| Price-to-Sales (P/S) Ratio | 87.81 | 55.12 | 88.86 | 299.33 | 0.00 |
| Price-to-Book (P/B) Ratio | 5.70 | 2.24 | 1.22 | 1.51 | 2.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.78 | -4.85 | -3.65 | -2.06 | -4.08 |
| Price-to-Operating Cash Flow Ratio | -14.24 | -5.02 | -4.47 | -5.28 | -7.42 |
| Price-to-Earnings Growth (PEG) Ratio | 0.24 | -0.28 | 0.08 | -0.34 | -0.00 |
| Enterprise Value Multiple | -19.27 | -5.09 | -3.72 | -3.19 | -6.14 |
| Enterprise Value | 42.97M | 24.14M | 16.45M | 22.43M | 36.53M |
| EV to EBITDA | -19.27 | -5.09 | -3.72 | -3.19 | -6.14 |
| EV to Sales | 100.80 | 61.91 | 90.86 | 277.89 | 0.00 |
| EV to Free Cash Flow | -15.82 | -5.44 | -3.73 | -1.91 | -3.33 |
| EV to Operating Cash Flow | -16.35 | -5.64 | -4.57 | -4.90 | -6.07 |
| Tangible Book Value Per Share | 2.05 | 0.11 | 0.15 | 0.21 | 0.30 |
| Shareholders’ Equity Per Share | 2.05 | 0.11 | 0.15 | 0.21 | 0.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Revenue Per Share | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.16 | -0.07 | -0.06 | -0.09 | -0.09 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.17 | 1.08 | 1.01 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.82 | 0.37 | 0.84 | 1.65 | 0.00 |
| SG&A to Revenue | 6.38 | 10.24 | 19.66 | 60.74 | 0.00 |
| Stock-Based Compensation to Revenue | 0.11 | 0.15 | 0.90 | 12.45 | 0.00 |
| Income Quality | 0.71 | 0.71 | 0.69 | 0.62 | 1.00 |
Currency in CAD
